Lenalidomide+dexamethasone (DrugBank: Lenalidomide, Dexamethasone)
7 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
16 | クロウ・深瀬症候群 | 1 |
26 | HTLV-1関連脊髄症 | 0 |
28 | 全身性アミロイドーシス | 0 |
34 | 神経線維腫症 | 0 |
49 | 全身性エリテマトーデス | 0 |
284 | ダイアモンド・ブラックファン貧血 | 0 |
300 | IgG4関連疾患 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02193698 (ClinicalTrials.gov) | July 2014 | 16/7/2014 | Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial | Single Arm Open-label Trial to Investigate the Efficacy and Safety of Lenlidomide as a Treatment for Recurrent or Refractory Crow-Fukase (POEMS) Syndrome | POEMS Syndrome | Drug: Lenalidomide+Dexamethasone | Chiba University | NULL | Completed | 20 Years | N/A | Both | 5 | Phase 2 | Japan |